NSAID use and clinical outcomes in COVID-19 patients: A 38-center retrospective cohort study

Mostrar otras versiones (1)

BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used to reduce pain, fever, and inflammation but have been associated with complications in community-acquired pneumonia. Observations shortly after the start of the COVID-19 pandemic in 2020 suggested that ibuprofen was associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Reese, Justin T., Coleman, Ben, Chan, Lauren, Blau, Hannah, Callahan, Tiffany J., Cappelletti, Luca, Fontana, Tommaso, Bradwell, Katie Rebecca, Harris, Nomi L., Casiraghi, Elena, Valentini, Giorgio, Karlebach, Guy, Deer, Rachel, McMurry, Julie A., Haendel, Melissa A., Chute, Christopher G., Pfaff, Emily, Moffitt, Richard, Spratt, Heidi, Singh, Jasvinder, Mungall, Christopher J., Williams, Andrew E., Robinson, Peter N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077581/
https://www.ncbi.nlm.nih.gov/pubmed/33907758
http://dx.doi.org/10.1101/2021.04.13.21255438

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077581/
https://www.ncbi.nlm.nih.gov/pubmed/33907758
http://dx.doi.org/10.1101/2021.04.13.21255438

Ejemplares similares